Rosalind Advisors Inc. 13D and 13G filings for PhaseBio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:12 pm Sale | 2021-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | Rosalind Advisors Inc. | 707,467 1.500% | -1,900,390 (-72.87%) | Filing |
| 2021-05-19 2:25 pm Purchase | 2021-05-12 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | Rosalind Advisors Inc. | 2,607,857 5.400% | 2,607,857 (New Position) | Filing |